Central administration of palmitoylethanolamide decreases hyperalgesia in mice by using inhibition of NF‐κB nuclear signalling in dorsal root ganglia. Eur J Pharmacol A clinical example of hyperalgesia could possibly be an amputee who is not able to make use of a prosthesis as a consequence of tenderness overlying the https://rafaeluwtno.blog-a-story.com/10679989/facts-about-palmitoylethanolamide-revealed